Logo

The US FDA Grants EUA for Quanterix's Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test

Share this

The US FDA Grants EUA for Quanterix's Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test

Shots:

  • The FDA has issued a EUA for Simoa Semi-Quantitative SARS-CoV-2 IgG Ab test and can be operated on Simoa HD-X Analyzer
  • The test checks for Abs that are directed against the spike protein. The test delivers a numerical result demonstrating Ab concentration ranging from 0.21-250mg/mL. The clinical studies demonstrated that the test had a 100% sensitivity and 99.2% specificity- 15 days or more after a positive PCR test
  • The instrument can be used to measure IgG Abs in patients suspected of prior infection or those who have lately been exposed to SARS-CoV-2

 ­ Ref: Businesswire | Image: Quanterix

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions